NanoVibronix (NAOV) said Friday it completed its acquisition of privately-held ENvue Medical Holdings in a stock-for-stock transaction.

Under the deal, all of ENvue's outstanding equity interests were exchanged based on a fixed exchange ratio for consideration as a combination of about 1.7 million NanoVibronix common shares and 57,720 shares of series X non-voting convertible preferred stock, NanoVibronix said.

The company said that after the completion of the deal, a successor-in-interest of ENvue will be a wholly-owned unit of NanoVibronix.

The company also said concurrently with the deal's closing, it sold a $500,000 senior convertible debenture in a private placement.

NanoVibronix shares were up nearly 2% in recent trading.

Price: 0.48, Change: +0.01, Percent Change: +1.93